Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection

doi:10.3748/wjg.v20.i11.2955

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 11

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6126)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

439

WORD

252

HTML

3090

Figures (1-1)

119

Tables (1-1)

128

Sum=4028

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1097

Download

1001

Sum=2098

Mar 21, 2014 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Mar 21, 2014; 20(11): 2955-2961
Published online Mar 21, 2014. doi: 10.3748/wjg.v20.i11.2955

Open in New Tab Full Size Figure Download Figure

Figure 1 The treatment of patients with dual chronic hepatitis C/B and the durability of the hepatitis C virus response. A: Hepatitis C virus (HCV) sustained virologic response (SVR) rate at 6 mo after end of peg-interferon plus ribavirin combination treatment; B: Durability of HCV SVR in patients who initially obtained HCV SVR at 6 mo after end of therapy. Median 4.6-years (range: 1-5 years) post-treatment follow-up. SVR: Sustained virologic response; Peg-IFN: Peg-interferon; RBV: Ribavirin.

Citation: Liu CJ, Chen PJ. Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection. World J Gastroenterol 2014; 20(11): 2955-2961
URL: https://www.wjgnet.com/1007-9327/full/v20/i11/2955.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i11.2955